The Morning Rush

The Morning Rush

The Morning Rush wakes you up on 97.5 WCOS every weekday morning. Drive to work while you listen to Jonathon Rush and Kelly Nash.Full Bio

 

New Brain Cancer Drug Could Be Game-changer

10 patients with advanced glioblastoma, the type of brain tumor that killed Joe Biden’s son, Beau were put into a trial of a combination of treatments and it's amazing researchers. Currently it has a survival rate of 7% for 5 years or longer. Two people with advanced brain cancer have responded well to the combo of chemo and immunotherapy drugs. And in one case, the life-threatening tumor “seems to have disappeared.”

Doctors at the Institute of Cancer Research and the Royal Marsden hospital in London are conducting Phase 1 of a trial called Ice-Cap andt say it’s “unusual” to have such a good response in patients this early in a trial. One of those patients Hamish Mykura, 59 was diagnosed with glioblastoma in August 2018. He underwent traditional treatment with minimal effect. In August 2019, he joined the Ice-Cap trial. Twenty months on, Hamish is cancer free.

Patients with glioblastoma don’t have good survival rates, but this could be a turning point. Dr. Juanita Lopez, leader of the study, explains, “We believe that our findings open the door to the further development of what could become a game-changing treatment option for some patients with aggressive glioblastoma brain cancer.”

FRANCE-HEALTH-HOSPITAL-SCIENCE-RESEARCH

Sponsored Content

Sponsored Content